Hui Zhou

机构：Academy of Medical Sciences, Sichuan University, Innovate UK, West China Hospital of Sichuan University, Guang’anmen Hospital, Guangxi Academy of Sciences · ORCID：0009-0000-0642-8663

发表论文 100 篇 · 总被引 5147 次 · h-index 27

代表论文

• Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer (2023 · JAMA · 被引 385)
• Polysaccharide from Panax japonicus C.A. Mey prevents non-alcoholic fatty liver disease development based on regulating liver metabolism and gut microbiota in mice (2024 · International Journal of Biological Macromolecules · 被引 26)
• Synthesis and preclinical evaluation of novel 18F-labeled fibroblast activation protein tracers for positron emission tomography imaging of cancer-associated fibroblasts (2023 · European Journal of Medicinal Chemistry · 被引 22)
• The first-in-class bispecific antibody IBI318 (LY3434172) targeting PD-1 and PD-L1 in patients with advanced tumors: a phase Ia/Ib study (2024 · Journal of Hematology & Oncology · 被引 19)
• Adult acute leukemia patients with gram-negative bacteria bloodstream infection: Risk factors and outcomes of antibiotic-resistant bacteria (2024 · Annals of Hematology · 被引 12)
• A multicenter study: predicting KRAS mutation and prognosis in colorectal cancer through a CT-based radiomics nomogram (2024 · Abdominal Radiology · 被引 8)